EUVIMEDAtrasti EUVIMED
Randomisierte kontrollierte StudieStudienprotokollOpen access

Culturally Tailored Diabetes Self-Management Education and Support Programs in Black African and Caribbean Adults With Type 2 Diabetes (HEAL-D): Protocol for a Multicenter, Pragmatic Randomized Controlled Trial

Kulturell angepasste Programme zur Diabetes-Selbstmanagement-Schulung und -Unterstützung bei schwarzen afrikanischen und karibischen Erwachsenen mit Typ-2-Diabetes (HEAL-D): Protokoll für eine multizentrische, pragmatische randomisierte kontrollierte Studie

Louise M Goff iD, Drusus A Johnson iD, Vicky Bell iD, Susan Blyden iD, Peter Bower iD, Jeremy Dale iD, Tess Harris iD, Andrew Healey iD, Eleanor Hoverd iD, Huajie Jin iD, Tony Kelly, Carol Rivas iD and 6 more

JMIR Research Protocols · 2025-09-30 · 14 · e71861

DOI: 10.2196/71861 ↗

Auf einen Blick

Die HEAL-D-Studie prüft ein kulturell angepasstes Gruppenprogramm für schwarze afrikanische und karibische Erwachsene mit Typ-2-Diabetes. Primärer Endpunkt ist HbA1c nach 12 Monaten; Ergebnisse liegen noch nicht vor.

Fragestellung

Ist HEAL-D im Vergleich zu standardisierten DSMES-Programmen klinisch und kosteneffektiv bei schwarzen afrikanischen und karibischen Erwachsenen mit Typ-2-Diabetes?

Methode

24-monatige, multizentrische, pragmatische, offene 2-armige Parallelgruppenstudie; 1:1-Randomisierung an 3 bis 5 Zentren im Vereinigten Königreich; primärer Endpunkt HbA1c nach 12 Monaten.

Ergebnisse

n=300 geplant. Rekrutierung begann im August 2024; am 26. März 2025 hatten 76 Teilnehmende zugestimmt. Primäre Datenanalyse ab Juli 2027 geplant.

Schlussfolgerung der Autor:innen

Die Studie soll zeigen, ob ein kulturell angepasstes DSMES-Programm klinisch und kosteneffektiv gegenüber Standard-DSMES ist. Bei Wirksamkeit könnte es ein Modell für gerechte DSMES-Angebote liefern.

Kernaussagen

  • HEAL-D ist ein kulturell angepasstes DSMES-Gruppenprogramm.
  • Verglichen wird mit einem Standard-DSMES-Programm.
  • Primärer Endpunkt ist HbA1c nach 12 Monaten.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Randomisierte kontrollierte Studie in JMIR Research Protocols, published online on 2025-09-30. Written by Louise M Goff and 17 co-authors. Institution: Diabetes Research Centre, University of Leicester, Leicester, United Kingdom. Major MEDLINE topics: Diabetes Mellitus, Type 2, Self-Management, Black People, Patient Education as Topic. Cited 1 times so far (Crossref); 74 references. The full text is freely available in PubMed Central. Funded by: National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA) Program (.

Auf einen BlickSantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Background

People of Black African and Black Caribbean ethnicity experience higher rates and poorer outcomes of type 2 diabetes (T2D) than people of White European ethnicity; these inequalities are compounded by poor healthcare access. Cultural tailoring of diabetes self-management education and support (DSMES) programs has the potential to improve healthcare engagement and clinical outcomes for ethnic minority groups. Healthy Eating & Active Lifestyles for Diabetes (HEAL-D) is a co-designed, culturally tailored group-based DSMES program for adults of Black African and Black Caribbean ethnicity.

Objective

This trial aims to evaluate the clinical and cost effectiveness of the HEAL-D intervention, compared to standard DSMES programs, in Black African and Black Caribbean adults living with T2D.

Methods

A 24-month, multicenter, pragmatic, open-label, 2-arm, parallel-group, individually randomized group treatment trial will be conducted, with primary end point (glycated hemoglobin [HbA1c]) assessment at 12 months. Black African and Black Caribbean adults with T2D (n=300), recruited from 3 to 5 centers in the United Kingdom (including London, West Midlands, and Greater Manchester), will be randomized in a 1:1 ratio to HEAL-D (intervention) or a standard DSMES program (control). HbA1c, blood lipids, anthropometric outcomes, blood pressure, physical activity, and patient-reported outcome measures relating to psychological well-being and self-management support, lifestyle behaviors, and health economics will be collected at baseline and follow-up visits (6, 12, and 24 months). Cost-effectiveness will be assessed through a cost-utility analysis conducted from a health and social care perspective. A mixed methods process evaluation will provide a formative evaluation of delivery, intervention fidelity, and implementation of HEAL-D, and an embedded study within a project will assess the impact of multiple long-term conditions on uptake of, and engagement with HEAL-D, and the impact of HEAL-D on multiple long-term conditions. The trial received Research Authority and Research Ethics Council approval on April 22, 2024.

Results

Funding began in August 2023. Site “green light” was received on August 15, 2024, for London; November 29, 2024, for Manchester; and January 31, 2025, for the West Midlands. Recruitment commenced in August 2024 and is due to run for 11 months. As of March 26, 2025, a total of 76 participants have consented. Last patient, last visit is expected in June 2027; primary data analysis is expected to begin in July 2027. Final results are anticipated to be available in September 2027, and publication is expected by the end of 2027.

Conclusions

The HEAL-D trial will address whether a culturally tailored DSMES program, provided in-person or via videoconferencing, is clinically and cost-effective compared to standard DSMES at improving diabetes management in Black African and Black Caribbean adults. If effective, this would provide an evidence-based model of equitable DSMES services and improve the implementation of healthcare programs for ethnic minority groups. Trial Registration ISRCTN 1434448; https://www.isrctn.com/ISRCTN14344948 International Registered Report Identifier (IRRID) DERR1-10.2196/71861

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, Type 2Self-ManagementBlack PeoplePatient Education as TopicHumansCaribbean RegionAdultFemaleMaleGlycated HemoglobinUnited KingdomMulticenter Studies as TopicMiddle AgedCost-Benefit AnalysisPragmatic Clinical Trials as Topic

Author keywords

clinical trialeducationethnicityprotocolself-managementtype 2 diabetes

Substances

Glycated Hemoglobin

Authors and institutions

  • Diabetes Research Centre, University of Leicester, Leicester, United Kingdom.
  • School of Health Sciences, University of Manchester, Manchester, United Kingdom.
  • Unit of Academic Primary Care, University of Warwick, Coventry, United Kingdom.
  • Population Health Research Institute, City St George's, University of London, London, United Kingdom.
  • King's Health Economics, King's College London, London, United Kingdom.
  • Public Citizen, Birmingham, United Kingdom.

ORCID profiles: Louise M Goff, Drusus A Johnson, Vicky Bell, Susan Blyden, Peter Bower, Jeremy Dale, Tess Harris, Andrew Healey, Eleanor Hoverd, Huajie Jin, Carol Rivas, Clare Robinson, Jayne Thorpe, Sandra Tomlinson, Michael Ussher, Charlotte Wahlich, Barbara McGowan

Funding

  • National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA) Program (

Cite

APA

Goff, L. M., Johnson, D. A., Bell, V., Blyden, S., Bower, P., Dale, J., Harris, T., Healey, A., Hoverd, E., Jin, H., Kelly, T., Rivas, C., Robinson, C., Thorpe, J., Tomlinson, S., Ussher, M., Wahlich, C., & McGowan, B. (2025). Culturally Tailored Diabetes Self-Management Education and Support Programs in Black African and Caribbean Adults With Type 2 Diabetes (HEAL-D): Protocol for a Multicenter, Pragmatic Randomized Controlled Trial. JMIR Research Protocols, 14, e71861. https://doi.org/10.2196/71861

Vancouver

Goff LM, Johnson DA, Bell V, Blyden S, Bower P, Dale J, et al. Culturally Tailored Diabetes Self-Management Education and Support Programs in Black African and Caribbean Adults With Type 2 Diabetes (HEAL-D): Protocol for a Multicenter, Pragmatic Randomized Controlled Trial. JMIR Research Protocols. 2025;14:e71861. doi:10.2196/71861

BibTeX
@article{Goff2025,
  author = {Goff, Louise M and Johnson, Drusus A and Bell, Vicky and Blyden, Susan and Bower, Peter and Dale, Jeremy and Harris, Tess and Healey, Andrew and Hoverd, Eleanor and Jin, Huajie and Kelly, Tony and Rivas, Carol and Robinson, Clare and Thorpe, Jayne and Tomlinson, Sandra and Ussher, Michael and Wahlich, Charlotte and McGowan, Barbara},
  title = {Culturally Tailored Diabetes Self-Management Education and Support Programs in Black African and Caribbean Adults With Type 2 Diabetes (HEAL-D): Protocol for a Multicenter, Pragmatic Randomized Controlled Trial},
  journal = {JMIR Research Protocols},
  year = {2025},
  volume = {14},
  pages = {e71861},
  doi = {10.2196/71861}
}
Start for free →